We are live on ! Find out more
SCI

S&CO Inc Portfolio holdings

AUM $1.61B
1-Year Est. Return 21.39%
This Fund
S&P 500
This Quarter Est. Return
+1.42%
1 Year Est. Return
+21.39%
3 Year Est. Return
+58.88%
5 Year Est. Return
+84.19%
10 Year Est. Return
+267.05%
AUM
$1.49B
AUM Growth
+$16.4M
Cap. Flow
+$17.1M
Cap. Flow %
1.15%
Top 10 Hldgs %
38.39%
Holding
221
New
11
Increased
53
Reduced
54
Closed
4

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$4.62M
2
UNH icon
UnitedHealth
UNH
+$3.99M
3
DBRG icon
DigitalBridge
DBRG
+$2.39M
4
MRK icon
Merck
MRK
+$2.17M
5
AMZN icon
Amazon
AMZN
+$2.01M

Sector Composition

Rank Sector Weight
1 Healthcare 17.45%
2 Technology 17.44%
3 Financials 11.3%
4 Materials 10.73%
5 Communication Services 10.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DASH icon
201
DoorDash
DASH
$80.1B
$245K 0.02%
1,341
CLH icon
202
Clean Harbors
CLH
$16.1B
$236K 0.02%
1,200
AVGO icon
203
Broadcom
AVGO
$1.81T
$234K 0.02%
1,400
CL icon
204
Colgate-Palmolive
CL
$73.3B
$224K 0.02%
2,400
VOO icon
205
Vanguard S&P 500 ETF
VOO
$965B
$217K 0.01%
423
+13
+3% +$7.03K
PFG icon
206
Principal Financial Group
PFG
$23.9B
$210K 0.01%
+2,500
New +$208K
IDXX icon
207
Idexx Laboratories
IDXX
$44B
$209K 0.01%
500
BE icon
208
Bloom Energy
BE
$51.7B
$196K 0.01%
10,000
ERII icon
209
Energy Recovery
ERII
$431M
$174K 0.01%
11,000
AES icon
210
AES
AES
$10.6B
$161K 0.01%
+13,000
New +$150K
ENVX icon
211
Enovix
ENVX
$897M
$161K 0.01%
25,143
CLNE icon
212
Clean Energy Fuels
CLNE
$434M
$93K 0.01%
60,000
+30,000
+100% +$76.2K
APP icon
213
Applovin
APP
$137B
-675
Closed -$218K
NOVA
214
DELISTED
Sunnova Energy
NOVA
-15,500
Closed -$53K
WST icon
215
West Pharmaceutical
WST
$23.2B
-2,600
Closed -$851K
ALTM
216
DELISTED
Arcadium Lithium plc
ALTM
-33,222
Closed -$170K

Similar funds

S&CO Inc's Q1 2025 Portfolio in Review

As of Q1 2025, S&CO Inc held 221 positions worth $1.49B, up 1.1% from $1.47B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

S&CO Inc's Q1 2025 filing shows 11 new, 53 increased, 54 reduced and 4 closed positions. Its largest new stake was Vertex Pharmaceuticals: 4,103 shares worth $1.99M. The largest sale was Apple, an estimated $6.62M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Technology and Financials.

  • S&CO Inc's largest Q1 2025 buy was Vertex Pharmaceuticals: 4,103 shares worth $1.99M.
  • S&CO Inc added most to Eli Lilly in Q1 2025, an estimated $4.62M increase.
  • S&CO Inc's biggest Q1 2025 reduction was Apple, cutting an estimated $6.62M.
  • S&CO Inc fully exited West Pharmaceutical in Q1 2025, selling an estimated $851K.
  • S&CO Inc's ten largest holdings make up 38% of its $1.49B portfolio in Q1 2025.
  • S&CO Inc opened 11 new positions and closed 4 in Q1 2025.
  • S&CO Inc's portfolio value rose 1.1% quarter-over-quarter to $1.49B.

Based on S&CO Inc's 13F filing for Q1 2025, filed 8 May 2025.